NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.83
-0.32 (-2.26%)
Mar 3, 2026, 4:00 PM EST - Market closed

NeuroPace Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
99.9979.9165.4245.5245.18
Revenue Growth (YoY)
25.13%22.14%43.72%0.75%9.83%
Cost of Revenue
22.7720.8217.313.0311.75
Gross Profit
77.2259.0948.1232.4933.44
Selling, General & Admin
65.6757.154.5251.3438.96
Research & Development
27.8923.6520.7821.9518.21
Total Operating Expenses
93.5680.7675.373.2957.17
Operating Income
-16.34-21.67-27.17-40.79-23.74
Interest Income
2.823.023.051.580.45
Interest Expense
-7.46-8.8-8.52-7.53-7.41
Other Non-Operating Income (Expense)
-0.490.3-0.32-0.34-5.38
Total Non-Operating Income (Expense)
-5.13-5.47-5.78-6.29-12.34
Pretax Income
-21.47-27.14-32.96-47.08-36.08
Net Income
-21.47-27.14-32.96-47.08-36.08
Net Income to Common
-21.47-27.14-32.96-47.08-36.08
Shares Outstanding (Basic)
3329262517
Shares Outstanding (Diluted)
3329262517
Shares Change (YoY)
12.35%12.67%5.11%48.08%8038.86%
EPS (Basic)
-0.66-0.93-1.27-1.91-2.17
EPS (Diluted)
-0.66-0.93-1.27-1.91-2.17
Free Cash Flow
-11.34-18.26-19.87-37.47-24.96
Free Cash Flow Per Share
-0.35-0.63-0.77-1.52-1.50
Gross Margin
77.23%73.94%73.56%71.38%74.00%
Operating Margin
-16.34%-27.12%-41.54%-89.62%-52.54%
Profit Margin
-21.47%-33.97%-50.38%-103.43%-79.85%
FCF Margin
-11.34%-22.85%-30.38%-82.32%-55.24%
EBITDA
-14.39-19.9-25.57-37.81-23.44
EBITDA Margin
-14.39%-24.91%-39.08%-83.06%-51.88%
EBIT
-16.34-21.67-27.17-40.79-23.74
EBIT Margin
-16.34%-27.12%-41.54%-89.62%-52.54%
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q